RxDoctor Payments Data

Juliana Vaughan

Pediatric Gastroenterology · Little Rock, ARNPI 1689890261

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Alcresta Therapeutics, Inc. accounts for 64.6% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $4,711, more than ten times the $291 reported in 2019.

$6,755in general payments, 2019–2025

Across 115 payments — averaging $58.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcresta Therapeutics, Inc.$4K
  • Takeda Pharmaceuticals U.S.A., Inc.$620
  • AbbVie$584
  • Sanofi$234
  • Ipsen Biopharmaceuticals, Inc$156
  • Regeneron Healthcare Solutions, Inc.$116
  • plus $678 from 13 others

What the payments were for

  • Speaking & faculty fees$3,15047%
  • Travel & lodging$85713%
  • Food & beverage$2,74741%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric gastroenterology providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Other pediatric gastroenterology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →